Literature DB >> 28679653

Reliable subtype classification of diffuse large B-cell lymphoma samples from GELA LNH2003 trials using the Lymph2Cx gene expression assay.

Jean-Philippe Jais1, Thierry Jo Molina1,2, Philippe Ruminy3, David Gentien4, Cecile Reyes4, David W Scott5, Lisa M Rimsza6, George Wright7, Randy D Gascoyne5, Louis M Staudt7, Corinne Haioun8, Herve Tilly3, Philippe Gaulard8, Gilles A Salles9, Fabrice Jardin3, Karen Leroy10.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28679653      PMCID： PMC5622872          DOI： 10.3324/haematol.2017.166827

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  11 in total

1.  A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma.

Authors:  George Wright; Bruce Tan; Andreas Rosenwald; Elaine H Hurt; Adrian Wiestner; Louis M Staudt
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-04       Impact factor: 11.205

2.  Precision medicine in diffuse large B-cell lymphoma: hitting the target.

Authors:  Joost S Vermaat; Steven T Pals; Anas Younes; Martin Dreyling; Massimo Federico; Igor Aurer; John Radford; Marie José Kersten
Journal:  Haematologica       Date:  2015-08       Impact factor: 9.941

3.  Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue.

Authors:  David W Scott; George W Wright; P Mickey Williams; Chih-Jian Lih; William Walsh; Elaine S Jaffe; Andreas Rosenwald; Elias Campo; Wing C Chan; Joseph M Connors; Erlend B Smeland; Anja Mottok; Rita M Braziel; German Ott; Jan Delabie; Raymond R Tubbs; James R Cook; Dennis D Weisenburger; Timothy C Greiner; Betty J Glinsmann-Gibson; Kai Fu; Louis M Staudt; Randy D Gascoyne; Lisa M Rimsza
Journal:  Blood       Date:  2014-01-07       Impact factor: 22.113

Review 4.  The molecular pathogenesis of primary mediastinal large B-cell lymphoma.

Authors:  Christian Steidl; Randy D Gascoyne
Journal:  Blood       Date:  2011-06-23       Impact factor: 22.113

5.  Young patients with non-germinal center B-cell-like diffuse large B-cell lymphoma benefit from intensified chemotherapy with ACVBP plus rituximab compared with CHOP plus rituximab: analysis of data from the Groupe d'Etudes des Lymphomes de l'Adulte/lymphoma study association phase III trial LNH 03-2B.

Authors:  Thierry Jo Molina; Danielle Canioni; Christiane Copie-Bergman; Christian Recher; Josette Brière; Corinne Haioun; Françoise Berger; Christophe Fermé; Marie-Christine Copin; Olivier Casasnovas; Catherine Thieblemont; Tony Petrella; Karen Leroy; Gilles Salles; Bettina Fabiani; Franck Morschauser; Nicolas Mounier; Bertrand Coiffier; Fabrice Jardin; Philippe Gaulard; Jean-Philippe Jais; Hervé Tilly
Journal:  J Clin Oncol       Date:  2014-11-10       Impact factor: 44.544

6.  Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response.

Authors:  Stefano Monti; Kerry J Savage; Jeffery L Kutok; Friedrich Feuerhake; Paul Kurtin; Martin Mihm; Bingyan Wu; Laura Pasqualucci; Donna Neuberg; Ricardo C T Aguiar; Paola Dal Cin; Christine Ladd; Geraldine S Pinkus; Gilles Salles; Nancy Lee Harris; Riccardo Dalla-Favera; Thomas M Habermann; Jon C Aster; Todd R Golub; Margaret A Shipp
Journal:  Blood       Date:  2004-11-18       Impact factor: 22.113

7.  Automated extraction of DNA and RNA from a single formalin-fixed paraffin-embedded tissue section for analysis of both single-nucleotide polymorphisms and mRNA expression.

Authors:  Guido Hennig; Mathias Gehrmann; Udo Stropp; Hiltrud Brauch; Peter Fritz; Michel Eichelbaum; Matthias Schwab; Werner Schroth
Journal:  Clin Chem       Date:  2010-10-14       Impact factor: 8.327

Review 8.  Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity.

Authors:  Laurie H Sehn; Randy D Gascoyne
Journal:  Blood       Date:  2014-12-11       Impact factor: 22.113

9.  Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study.

Authors:  Sydney Dubois; Pierre-Julien Viailly; Sylvain Mareschal; Elodie Bohers; Philippe Bertrand; Philippe Ruminy; Catherine Maingonnat; Jean-Philippe Jais; Pauline Peyrouze; Martin Figeac; Thierry J Molina; Fabienne Desmots; Thierry Fest; Corinne Haioun; Thierry Lamy; Christiane Copie-Bergman; Josette Brière; Tony Petrella; Danielle Canioni; Bettina Fabiani; Bertrand Coiffier; Richard Delarue; Frédéric Peyrade; André Bosly; Marc André; Nicolas Ketterer; Gilles Salles; Hervé Tilly; Karen Leroy; Fabrice Jardin
Journal:  Clin Cancer Res       Date:  2016-01-27       Impact factor: 12.531

10.  Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma.

Authors:  Andreas Rosenwald; George Wright; Karen Leroy; Xin Yu; Philippe Gaulard; Randy D Gascoyne; Wing C Chan; Tong Zhao; Corinne Haioun; Timothy C Greiner; Dennis D Weisenburger; James C Lynch; Julie Vose; James O Armitage; Erlend B Smeland; Stein Kvaloy; Harald Holte; Jan Delabie; Elias Campo; Emili Montserrat; Armando Lopez-Guillermo; German Ott; H Konrad Muller-Hermelink; Joseph M Connors; Rita Braziel; Thomas M Grogan; Richard I Fisher; Thomas P Miller; Michael LeBlanc; Michael Chiorazzi; Hong Zhao; Liming Yang; John Powell; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Richard D Klausner; Louis M Staudt
Journal:  J Exp Med       Date:  2003-09-15       Impact factor: 14.307
View more
  7 in total

1.  A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL.

Authors:  Zijun Y Xu-Monette; Hongwei Zhang; Feng Zhu; Alexandar Tzankov; Govind Bhagat; Carlo Visco; Karen Dybkaer; April Chiu; Wayne Tam; Youli Zu; Eric D Hsi; Hua You; Jooryung Huh; Maurilio Ponzoni; Andrés J M Ferreri; Michael B Møller; Benjamin M Parsons; J Han van Krieken; Miguel A Piris; Jane N Winter; Fredrick B Hagemeister; Babak Shahbaba; Ivan De Dios; Hong Zhang; Yong Li; Bing Xu; Maher Albitar; Ken H Young
Journal:  Blood Adv       Date:  2020-07-28

2.  Routine application of the Lymph2Cx assay for the subclassification of aggressive B-cell lymphoma: report of a prospective real-world series.

Authors:  Alberto Zamò; Elena Gerhard-Hartmann; German Ott; Ioannis Anagnostopoulos; David W Scott; Andreas Rosenwald; Hilka Rauert-Wunderlich
Journal:  Virchows Arch       Date:  2022-10-11       Impact factor: 4.535

Review 3.  Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications.

Authors:  Sotirios G Papageorgiou; Thomas P Thomopoulos; Ioannis Katagas; Anthi Bouchla; Vassiliki Pappa
Journal:  Ther Adv Hematol       Date:  2021-05-24

4.  Discriminant analysis and machine learning approach for evaluating and improving the performance of immunohistochemical algorithms for COO classification of DLBCL.

Authors:  Yocanxóchitl Perfecto-Avalos; Alejandro Garcia-Gonzalez; Ana Hernandez-Reynoso; Gildardo Sánchez-Ante; Carlos Ortiz-Hidalgo; Sean-Patrick Scott; Rita Q Fuentes-Aguilar; Ricardo Diaz-Dominguez; Grettel León-Martínez; Verónica Velasco-Vales; Mara A Cárdenas-Escudero; José A Hernández-Hernández; Arturo Santos; José R Borbolla-Escoboza; Luis Villela
Journal:  J Transl Med       Date:  2019-06-11       Impact factor: 5.531

Review 5.  Molecular Genetics of Relapsed Diffuse Large B-Cell Lymphoma: Insight into Mechanisms of Therapy Resistance.

Authors:  Madeleine R Berendsen; Wendy B C Stevens; Michiel van den Brand; J Han van Krieken; Blanca Scheijen
Journal:  Cancers (Basel)       Date:  2020-11-28       Impact factor: 6.639

Review 6.  Molecular Complexity of Diffuse Large B-Cell Lymphoma: Can It Be a Roadmap for Precision Medicine?

Authors:  Nicoletta Coccaro; Luisa Anelli; Antonella Zagaria; Tommasina Perrone; Giorgina Specchia; Francesco Albano
Journal:  Cancers (Basel)       Date:  2020-01-11       Impact factor: 6.639

Review 7.  Predictive and Prognostic Molecular Factors in Diffuse Large B-Cell Lymphomas.

Authors:  Stefano A Pileri; Claudio Tripodo; Federica Melle; Giovanna Motta; Valentina Tabanelli; Stefano Fiori; Maria Carmela Vegliante; Saveria Mazzara; Sabino Ciavarella; Enrico Derenzini
Journal:  Cells       Date:  2021-03-18       Impact factor: 6.600
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.